KALA BIO(DE:27F)
€3.400.00 (0.00%)
DE:27F
KALA BIO earnings date
€3.40
At close:0.00 (0.00%)
KALA BIO (27F) Q3 2022 Earnings Report
0 Followers
DE:27F Q3 2022 EPS Results
- Actual EPS
- EUR 873.13
- Consensus EPS
- EUR 487.59
- Beat/Miss
- Beat by +EUR 385.54
- One Year Ago EPS
- -EUR 975.19
DE:27F Q3 2022 Revenue Results
- Actual Revenue
- EUR 381.00K
- Expected Revenue
- EUR 56.70M
- Beat/Miss
- Missed by -EUR 56.32M
- YoY Revenue Growth
- -86.31%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 11/08/2022
- Time
- Before Open
- Conference Call
- Tuesday, November 8, 2022
Q3 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:27F Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Aug 06, 2026 | 2026 (Q2) | ―-19.34 | -77.56 | 75.07% (+58.22) | |
| May 19, 2026 | 2026 (Q1) | ―-0.12 | -63.95 | 99.81% (+63.83) | |
| Mar 26, 2026 | 2025 (Q4) | -0.290.02 | -1.58 | 101.44% (+1.60) | |
| Nov 17, 2025 | 2025 (Q3) | -0.92-0.92 | -1.75 | 47.67% (+0.83) | |
| Aug 08, 2025 | 2025 (Q2) | -77.26-77.56 | -143.33 | 45.89% (+65.77) | |
| May 14, 2025 | 2025 (Q1) | ―-1.58 | -190.5 | 99.17% (+188.92) | |
| Mar 31, 2025 | 2024 (Q4) | -92.08-63.95 | -190.5 | 66.43% (+126.55) | |
| Nov 12, 2024 | 2024 (Q3) | -110.22-87.54 | -154.67 | 43.40% (+67.13) | |
| Aug 06, 2024 | 2024 (Q2) | -199.80-143.33 | -197.76 | 27.52% (+54.43) | |
| May 14, 2024 | 2024 (Q1) | -131.08-190.50 | -317.05 | 39.91% (+126.55) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
